Skip to Main content Skip to Navigation

Discontinuités téchnologiques et business models : analyse des mécanismes de transformation de l'industrie du médicament

Abstract : In analyzing recent developments in the drug industry, this thesis brings new elements, both theoretical and empirical, on mechanisms for the transformation of high-technology industries. We seek to understand why the introduction of technological discontinuities does not necessarily lead to change in the industry and on how the dominant logic can be questioned. To address this problem, we used a qualitative approach. We interviewed drug industry experts, and analyzed eleven case studies of biotechnology and bioinformatics companies. Our first theoretical contribution is to propose the concept of dominant logic to complete research on industry life cycle, where we argue that technological discontinuities are a necessary, but not sufficient, condition to change the industry. The concept of dominant logic allows taking into account the general schemes of value creation and value capture that constrain the strategies of the firms that are in the industry. Our second theoretical contribution is to identify four mechanisms of challenge to the industry's dominant logic: new value propositions, alliances with large diversifying entrants, orchestration of networks, and portfolios of business models. Our third contribution is managerial. We offer a tool for the design of corporate strategy. This tool allows articulating promises and risks, medium and long term. Finally, our fourth contribution addresses managers and leaders of the drug industry. We suggest four ways of thinking about the design of their corporate strategies.
Document type :
Complete list of metadatas

Cited literature [213 references]  Display  Hide  Download
Contributor : Abes Star :  Contact
Submitted on : Friday, November 4, 2011 - 5:12:37 PM
Last modification on : Friday, November 6, 2020 - 4:43:59 AM
Long-term archiving on: : Sunday, February 5, 2012 - 2:29:07 AM


Version validated by the jury (STAR)


  • HAL Id : tel-00638419, version 1



Valérie Sabatier. Discontinuités téchnologiques et business models : analyse des mécanismes de transformation de l'industrie du médicament. Gestion et management. Université de Grenoble, 2011. Français. ⟨NNT : 2011GRENG002⟩. ⟨tel-00638419⟩



Record views


Files downloads